HOME › DRUGS › SEVELAMER HYDROCHLORIDE
ACTIVE SUBSTANCE / INN

SEVELAMER HYDROCHLORIDE

Brand name(s): Tasermity, RENAGEL, SEVELAMER HYDROCHLORIDE
FDA LISTED
EMA LISTED
PRESCRIPTION
LAPSED
DISCONTINUED
ANDA206883
Hyperphosphatemia;Renal Dialysis
ACTIVE SUBSTANCE
Sevelamer Hydrochloride
REGULATORS
FDA · EMA
SPONSORS / MAH
MACLEODS PHARMS LTD, RISING, GENZYME
TOTAL APPLICATIONS
5
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
SEVELAMER HYDROCHLORIDEANDA206883MACLEODS PHARMS LTDPrescription
SEVELAMER HYDROCHLORIDEANDA201068RISINGDiscontinued
RENAGELNDA021179GENZYMEPrescription
RENAGELNDA020926GENZYMEDiscontinued
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
TasermityGenzyme Europe BVLapsed25/02/2015Hyperphosphatemia;Renal Dialysis

FULL INTELLIGENCE ON SEVELAMER HYDROCHLORIDE

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →